Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03217058 · ClinicalTrials.gov registry record · NA
Computerized Substance Use and Depression Screening and Behavioral Treatment in HIV Primary Care
A NA study of Depression and Anxiety, sponsored by University of California, San Francisco.
- Completed
- Registry status
- NA
- Development phase
- 10,821
- Enrollment target
- 1
- Study location
NCT03217058: Completed NA study of Depression and Anxiety, sponsored by University of California, San Francisco.
NCT03217058 is a NA study of Depression and Anxiety that has completed, run by University of California, San Francisco. The registered enrollment target is 10,821 participants, above the 770-participant average among 679 other Depression trials with a reported enrollment target (1305% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03217058, a NA study of Depression and Anxiety, has completed, sponsored by University of California, San Francisco.
- COMPLETED
- Registry status
- NA
- Development phase
- 10,821 participants
- Enrollment target
- 1
- Study location
Study Summary
Substance use disorders (SUDs), depression and anxiety in HIV-infected patients result in poor HIV outcomes, yet are often unrecognized and untreated. To address these problems, this study examines the implementation and effectiveness of a clinical intervention consisting of self-administered tablet-based SUD and depression screening at routine HIV primary care clinic visits, followed by evidence-based treatments for SUD, anxiety and depression delivered by a behavioral health specialist. If successful, this study has potential to reduce SUD-, anxiety- and depression-related problems and reduce HIV treatment disparities for patients with these comorbidities.
Primary Outcome
Rate of screening using usual care methods (pre-implementation) compared with rate of screening using computerized methods, based on electronic health record (EHR) data.
Conditions Studied
Interventions
- BEHAVIORAL Clinic-based screening and behavioral interventions
Study Locations (1)
California
- Kaiser Permanente Division of Research - Oakland
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10,821 participants |
| Start Date | 2016-08-01 |
| Est. Completion | 2020-07-31 |
| Phase | NA |
What the finished NCT03217058 record still lists
NCT03217058 is an interventional study that assigns participants to a tested intervention. Its 10,821 participants enrollment target places it among the larger protocols in the corpus, above the 770-participant average among 679 other Depression trials with a reported enrollment target (1305% higher).
The record links to 4 conditions, with Depression appearing as the primary indexed condition, and to 1 intervention - of which Clinic-based screening and behavioral interventions is the first listed.
NCT03217058 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT03217058 about?
NCT03217058 is a clinical study titled "Computerized Substance Use and Depression Screening and Behavioral Treatment in HIV Primary Care". Substance use disorders (SUDs), depression and anxiety in HIV-infected patients result in poor HIV outcomes, yet are often unrecognized and untreated. To address these problems, this study examines the implementation and effectiveness of a clinical intervention consisting of self-administered tablet...
What is the current status of trial NCT03217058?
This trial is currently completed. It is a NA study. The enrollment target is 10,821 participants. The study started on 2016-08-01. Estimated completion is 2020-07-31.
What conditions does trial NCT03217058 study?
This clinical trial studies the following conditions: Depression, Anxiety, HIV, Substance Use Disorders.
What interventions are being tested in trial NCT03217058?
The interventions under investigation include: Clinic-based screening and behavioral interventions (BEHAVIORAL).
Who is sponsoring clinical trial NCT03217058?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03217058 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Depression
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03217058's enrollment target sits among peer trials
10,821 7th of 679 higher than 673 of 679 other Depression trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Depression trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Reaching Out to Distressed Medical Residents, Fellows and Faculty
RECRUITING · NA
-
IMPACT (IMproving Proactive Approaches for Cancer Survivors' Mental Health Treatment)
RECRUITING · NA
-
Cold and Heat Investigation to Lower Levels of Depression
RECRUITING · NA
-
Dosing rTMS for Depression Post-SCI
RECRUITING · NA
-
Exploring Virtual Reality Adventure Training Exergaming
RECRUITING · NA
-
Brief Interventions for Coping with Distress
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06736951 · 10,890 participants · NA
Modifying the Inpatient Environment to Reduce Delirium in Older Adults
- NCT06468202 · 10,742 participants · Phase 4
Effectiveness of Two Aspirin Doses for Prevention of Hypertensive Disorders of Pregnancy: ASPIRIN TRIAL
- NCT06531824 · 11,000 participants · Phase 3
EASi-KIDNEY™ (The Studies of Heart & Kidney Protection With BI 690517 in Combination With Empagliflozin)
- NCT07136012 · 11,000 participants · Phase 3
OCEAN(a)-PreEvent - Olpasiran Trials of Cardiovascular Events And LipoproteiN(a) Reduction to Prevent First Major Cardiovascular Events
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT06358040 · started 2026-10 · NA
Opioid Dispenser for Microdiscectomy/Laminectomy